As of 2026-01-07, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (68.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.37 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -516.1%.
The range of the Relative Valuation is (66.77) - (72.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 18.8x | 16.5x |
| Forward P/E multiples | 17.3x - 20.2x | 18.8x |
| Fair Price | (66.77) - (72.63) | (68.12) |
| Upside | -507.9% - -543.7% | -516.1% |
| Date | P/E |
| 2026-01-06 | -4.24 |
| 2026-01-05 | -4.10 |
| 2026-01-02 | -4.07 |
| 2025-12-31 | -4.30 |
| 2025-12-30 | -4.38 |
| 2025-12-29 | -4.46 |
| 2025-12-26 | -4.55 |
| 2025-12-24 | -4.58 |
| 2025-12-23 | -4.47 |
| 2025-12-22 | -4.63 |
| 2025-12-19 | -4.54 |
| 2025-12-18 | -4.22 |
| 2025-12-17 | -3.98 |
| 2025-12-16 | -3.95 |
| 2025-12-15 | -3.81 |
| 2025-12-12 | -3.77 |
| 2025-12-11 | -3.78 |
| 2025-12-10 | -3.77 |
| 2025-12-09 | -3.68 |
| 2025-12-08 | -3.86 |
| 2025-12-05 | -3.78 |
| 2025-12-04 | -3.81 |
| 2025-12-03 | -3.80 |
| 2025-12-02 | -3.82 |
| 2025-12-01 | -3.87 |
| 2025-11-28 | -4.05 |
| 2025-11-26 | -3.93 |
| 2025-11-25 | -3.87 |
| 2025-11-24 | -3.84 |
| 2025-11-21 | -3.89 |
| 2025-11-20 | -3.72 |
| 2025-11-19 | -3.83 |
| 2025-11-18 | -3.89 |
| 2025-11-17 | -3.73 |
| 2025-11-14 | -3.77 |
| 2025-11-13 | -3.85 |
| 2025-11-12 | -3.79 |
| 2025-11-11 | -3.72 |
| 2025-11-10 | -3.56 |
| 2025-11-07 | -3.43 |
| 2025-11-06 | -3.38 |
| 2025-11-05 | -3.44 |
| 2025-11-04 | -3.50 |
| 2025-11-03 | -3.56 |
| 2025-10-31 | -3.51 |
| 2025-10-30 | -3.45 |
| 2025-10-29 | -3.51 |
| 2025-10-28 | -3.51 |
| 2025-10-27 | -3.58 |
| 2025-10-24 | -3.51 |